Novo Nordisk presents phase 3 data for next-generation amylin cagrilintide, leading to advancement into dedicated clinical programme US$ 27.05 Min. order: 1 piece ★★★★★ 4.2 (78 reviews) Sold : Login>>
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity US$ 20.11 Min. order: 1 piece ★★★★★ 4.1 (59 reviews) Sold : Login>>
New semaglutide and cagrilintide/semaglutide results US$ 23.95 Min. order: 1 piece ★★★★★ 4.8 (51 reviews) Sold : Login>>
Novo Nordisk presents new Phase III data for next-gen amylin cagrilintide US$ 24.64 Min. order: 1 piece ★★★★★ 4.3 (100 reviews) Sold : Login>>
Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes US$ 22.07 Min. order: 1 piece ★★★★★ 4.1 (183 reviews) Sold : Login>>
Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had ≥1 weight-related complication, individuals assigned to a combination US$ 23.48 Min. order: 1 piece ★★★★★ 4.2 (60 reviews) Sold : Login>>